3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
17
Stomach Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Rectal Neoplasms
5
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Nasopharyngeal Carcinoma
3
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Solid Tumor
2
Recurrence
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Resectable NSCLC
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Metastatic Gastroesophageal Junction Adenocarcinoma
1
Meningeal Carcinomatosis
1
MSI-H
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Magnetic Resonance Spectroscopy
18
pembrolizumab
16
Specimen Handling
15
Cisplatin
14
Carboplatin
9
Platinum
8
Cetuximab
8
1,2-diaminocyclohexaneplatinum II citrate
8
Radiotherapy, Intensity-Modulated
7
Radiation
7
Paclitaxel
7
Biopsy
7
Taxes
6
Radiotherapy
6
cemiplimab
4
X-Rays
4
Standard of Care
4
Nivolumab
4
Drug Therapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Ultrasonography
3
Surgical Procedures, Operative
3
Sentinel Lymph Node Biopsy
3
Observation
3
Immunoglobulin G
3
Disulfides
3
ipatasertib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
sintilimab
×
1 year
×
Clear all
No trials found.